All In MedTech

Device Trial Radar · NCT01117779

Tracking Renal Tumors After Cryoablation Evaluation

Tracking Renal Tumors After Cryoablation Evaluation (TRACE) Registry

Last checked: Nov 19, 2026Latest source record: Jan 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

246

Actual

Start

Jul 9, 2010

Primary completion

Nov 24, 2020

Study completion Nov 24, 2020

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
May 5, 2010

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

TRACE is an observational, open-label, single-arm, multi-center registry of subjects who have undergone renal lesion cryoablation per their physician's standard of care. Patients 18 years of age or older who have been determined to be an appropriate candidate for cryoablation will be offered enrollment into the registry. Subjects will be observed for five years from the date of their cryoablation procedure.

Conditions

  • Kidney Neoplasms

Interventions

  • CryoablationDevice

    Cryoablation (freezing) with Galil Medical cryoablation systems and needles under imaging guidance

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Changes in Lesion SizeTime frame: Baseline and months 6, 12, 24, 36, 48 and 60
  2. Renal Function StatusTime frame: Baseline and months 6, 12, 24, 36, 48 and 60
  3. Hospital StayTime frame: Average duration of 2 days or longer

6 more outcomes with a free account

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • University of California Irvine

    Orange, California

  • Kaiser Permanente

    Denver, Colorado

  • University of Kentucky

    Lexington, Kentucky

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.